Section Arrow
AXSM.NASDAQ
- Axsome Therapeutics
Quotes are at least 15-min delayed:2026/05/26 05:58 EDT
Pre Market
Last
 236.17
+0.2 (+0.08%)
Bid
229.03
Ask
240
High 238 
Low 236.17 
Volume 107 
Regular Hours (Closed)
Last
 235.97
+2.33 (+1.00%)
Day High 
236.84 
Prev. Close
233.64 
1-M High
235.915 
Volume 
674.62K 
Bid
229.03
Ask
240
Day Low
232.02 
Open
235 
1-M Low
180 
Market Cap 
12.02B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 227.15 
20-SMA 215.89 
50-SMA 188.36 
52-W High 235.915 
52-W Low 96.09 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.72/5.48
Enterprise Value
12.17B
Balance Sheet
Book Value Per Share
1.06
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
638.50M
Operating Revenue Per Share
4.34
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GOVXGeoVax Labs Inc.3.64+0.89+32.36%-- 
Pre Market 3.8605 +0.2205 +6.06%
MTVAMetaVia Inc.3.85+0.98+34.15%-- 
Pre Market 3.4269 -0.4231 -10.99%
AKTXAkari Therapeutics Plc18.27+13.13+255.45%-- 
Pre Market 13.9889 -4.2811 -23.43%
LIMNLiminatus Pharma Inc0.1694-0.0766-31.14%-- 
Pre Market 0.1601 -0.0093 -5.49%
IOVAIovance Biotherapeutics4.11+0.41+11.08%-- 
Pre Market 4.04 -0.07 -1.70%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.